Document is current
Any future updates will be listed below
-
Authors
Liu, Siyao
Thennavan, Aatish
Garay, Joseph P.
Marron, J. S.
Perou, Charles M. https://orcid.org/0000-0001-9827-2247
-
Funding
Funding for this research was provided by:
National Cancer Institute Breast SPORE program (P50-CA58223)
RO1 (RO1-CA14876)
National Institutes of Health (U01CA238475-01)
Breast Cancer Research Foundation
Susan G. Komen (SAC-160074)
- License Information
-
More Information
Article History
Received: 19 March 2021
Accepted: 29 July 2021
First Online: 19 August 2021
Declarations
:
: Not applicable.
: C.M.P is an equity stock holder and consultant of BioClassifier LLC; C.M.P is also listed as an inventor on patent applications for the Breast PAM50 Subtyping assay.
